5HTTLPR Polymorphism and Enlargement of the
Pulvinar: Unlocking the Backdoor to the Limbic System
Keith A. Young, Leigh A. Holcomb, Willy L. Bonkale, Paul B. Hicks, Umar Yazdani, and Dwight C. German
Background: The 5HTTLPR genetic variant of the serotonin transporter (SERT), which consists of a long (SERT-l) and short (SERT-s) allele, has
emerged as a major factor influencing emotional behavior and brain anatomy. The pulvinar nucleus of the thalamus projects to important
limbic nuclei including the amygdala and cingulate cortex, is involved in the processing of stimuli with emotional content, and contains an
abundance of SERT.
Methods: Stereological methods were used to measure pulvinar neuron number in postmortem tissue from major depressive disorder (n
11), bipolar disorder (n 11), schizophrenia (n 12), and control (n 15) specimens from the Stanley Foundation Neuropathology
Consortium. The effect of SERT genotype on pulvinar volume and neuron number was investigated by using analysis of covariance.
Results: Analysis of covariance with diagnosis, SERT genotype, age, hemisphere, postmortem interval, and time-in-formalin covariates
identified a 20% increase in pulvinar neuron number and volume in SERT-ss subjects.
Conclusions: The elevated number of pulvinar neurons in subjects with a SERT-ss genotype may serve to enhance subcortical input of
emotionally relevant stimuli to the limbic system, providing a mechanism for the 5HTTLPR genetic variant to affect predisposition to
conditions such as major depression.
Key Words: Depression, human, postmortem, pulvinar, serotonin,
thalamus
T
he serotonin transporter (SERT) plays an important role in
regulating serotonin (5HT) levels in the brain by transport-
ing 5HT from the extracellular space into the neuron. A
44 – base pair polymorphism in the transcriptional control region
upstream of the coding sequence of the SLC6A4 SERT gene (5HT
transporter-linked polymorphic region; 5HTTLPR) results in
short (SERT-s) and long (SERT-l) alleles. Although this genetic
variant does not directly affect amino-acid sequence, it can alter
SERT expression (Bradley et al 2005; Lesch et al 1996). Inheri-
tance of the SERT-s allele has been associated with a heightened
response of the limbic system to emotional stimuli (Hariri et al
2005; Pezawas et al 2005), elevated levels of subclinical depres-
sive symptoms (Gonda et al 2005), and an increased incidence of
major depression and suicidal behavior (Hoefgen et al 2005; Lin
and Tsai 2004). In addition, 5HTTLPR genetic variants have been
associated with a variety of emotion-related behaviors and
conditions, including shyness, aggression, anxiety, bipolar disor-
der, posttraumatic stress disorder, autism, and attention-deficit/
hyperactivity disorder (Arbelle et al 2005; Cho et al 2005; Curran
et al 2005; Gerra et al 2005; Lee et al 2005; Yirmiya et al 2001; You
et al 2005).
Genetic variation of 5HTTLPR is emerging as an important
factor contributing to structural changes in the brain. In a recent
study, Pezawas and colleagues (2005) found that normal, non-
psychiatric SERT-s carriers have a 25% reduction in the volume of
the anterior cingulate cortex and a 15% reduction in the volume
of the amygdala. In addition to reduced volumes, the study
identified functional alterations in limbic circuits in SERT-s
carriers. These data are compelling because the anterior cingu-
late cortex and amygdala are intimately involved in the process-
ing of emotional responses, and identification of anatomical
changes in these limbic circuits raises the possibility that SERT-s
carriers possess a unique brain structural phenotype predispos-
ing them to depression and related disorders.
The thalamus participates in the neural processing of emotion
and mood by mediating information flow within the limbic system
and cerebral cortex (Alexander et al 1986). For example, during an
endogenous depressive episode, or when symptoms of depression
are induced experimentally by a reduction in serotonin synthesis,
there are metabolic alterations in the thalamus (Drevets 2003;
Neumeister et al 2004). In addition to processing ongoing activity
of the limbic system, the pulvinar nucleus of the thalamus
receives visual and auditory sensory signals and relays informa-
tion related to the emotional content of the environment into the
limbic system (Ohman 2005). This nucleus directly is connected
to both the anterior cingulate cortex and the amygdala (Jones
and Burton 1976; Romanski et al 1997). Because the thalamus
contains one of the highest levels of SERT in the human brain
(Frankle et al 2004) and because SERT is intimately involved in
thalamic development and function (Esaki et al 2005; Monckton
and McCormick 2002; Persico et al 2001), we investigated the
possibility that 5HTTLPR genotype influences thalamic anatomy
by measuring neuron number and volume of the pulvinar in
postmortem tissue from normal and psychiatric patients of the
Stanley Foundation Neuropathology Consortium. The data indi-
cate that the SERT-ss genotype is associated with an enlargement
of the pulvinar, an anatomic variation that may enhance input of
emotionally relevant stimuli into the limbic system and provide a
mechanism for predisposition to psychiatric conditions associ-
ated with alterations in emotion and mood.
Methods and Materials
Forty-nine specimens from the Stanley Foundation Neuropa-
thology Consortium (Torrey et al 2000), with a complete series of
From the Neuropsychiatry Research Program, Central Texas Veterans Health
Care System (KAY, LAH, WLB, PBH) and the Texas A&M Health Science
Center, Department of Psychiatry and Behavioral Science (KAY, LAH,
WLB, PBH), Temple, Texas; and the Department of Psychiatry, University
of Texas Southwestern Medical School (UY, DCG), Dallas, Texas.
Address reprint requests to Keith A. Young, Ph.D., Central Texas Veterans
Health Care System, Neuropsychiatry Research Program (151N), 1901 S.
1st Street, Temple, TX 76504; E-mail: kayoung@medicine.tamhsc.edu.
Received February 21, 2006; revised August 2, 2006; accepted August 28,
2006.
BIOL PSYCHIATRY 2007;61:813– 818 0006-3223/07/$32.00
doi:10.1016/j.biopsych.2006.08.047 © 2007 Society of Biological Psychiatry